Support: 888-992-3836
|
NewsWire
|
Home
|
Login / Register
Boards
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
Hot!
Breakout Boards
Follow Feed
iHub My Stocks Activity
Ticker Buzz Cloud
Most Read
Most Posted
Most Followed Members
Recent News
News By Market
Active Boards
Site Stats
New Boards
Cannabis Stocks
Top PlusOneCoin Posters
Tools
Data Tools >
Charts
Trader Alerts
Trades
Portfolio
Top Lists
Price & News Alerts
Commodities
NewsWire
More Tools >
Newsletters
InvestorsHub Daily
My Image Gallery
Advanced Search
All News
Stock Screener
News Filter
Live Charts
Live News
Live Desktop
Forex Prices
Commodities
Educational Channel
Follow Feed
News Scanner
Crypto
Top Cryptocurrencies
PLUS1 Info & Faucet
Top Tokens
New Cryptocurrencies
Crypto Converter
Streamer
Level 2
Home
>
Boards
>
US Listed
>
Medical - Drugs
>
Abbott Laboratories (ABT)
Add ABT Price Alert
Hide Sticky
Hide Intro
Moderator:
DewDiligence
Search This Board:
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003+
Last Post:
5/18/2022 9:11:10 AM
-
Followers:
43
- Board type:
Free
- Posts Today:
0
ABT Investor Relations
ABT
Current Price
Volume:
Bid
Ask
Day's Range
ABT Detailed Quote
1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y
ABT News: New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies
05:15 AM
ABT News: New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies
05:15 AM
ABT News: Abbott Enters into Consent Decree with U.S. Food and Drug Administration for its Sturgis, Mich., Plant; Agreement Creates Pathway to Reopen Facility
05/16/2022 12:22:00 PM
ABT News: Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials
05/11/2022 05:00:00 AM
ABT News: Statement of Changes in Beneficial Ownership (4)
05/05/2022 02:17:10 PM
News Alert:
New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies
05/19/2022 05:15:00 AM
Post New Msg
My Stocks (90)
Hide Intro
View Posters
ABT Poststream
Bans (0)
Hide Quote
Filter Disabled
Post
Subject
#754
should be $140
NOLA1961
05/18/22 09:11:10 AM
#753
ABT $120 TARGET PRICE TODAY
weedtrader420
05/17/22 07:23:34 AM
#752
It
was
hit pretty hard in February, when
DewDiligence
05/13/22 11:09:53 AM
#751
Surprised the stock wasn't hit massively.........
Termite7
05/13/22 09:50:21 AM
#750
ABT infant-formula plant expected back online soon:
DewDiligence
05/11/22 05:37:24 PM
#749
Thanks. Was looking for a non Seeking alpha source
Hunting_for_multiples
04/21/22 09:32:06 PM
#748
1Q22 FreeStyle Libre sales were $1.0B (yes, a
DewDiligence
04/20/22 06:00:32 PM
#747
ABT 1Q22 CC transcript:
DewDiligence
04/20/22 05:28:12 PM
#745
ABT 1Q22 Results by Business Segment [pre]
DewDiligence
04/20/22 12:57:11 PM
#744
ABT sold $3.3B of COVID diagnostics in 1Q22:
DewDiligence
04/20/22 10:49:15 AM
#743
CDC unable_to_link infant-formula contamination_to ABT’s manufacturing plant:
DewDiligence
04/18/22 11:08:21 AM
#742
ABT fell 6% cumulatively_on_Thu/Fri_due_to infant-formula recall:
DewDiligence
02/21/22 12:47:18 PM
#741
ABT 4Q21 CC transcript:
DewDiligence
01/26/22 07:48:13 PM
#740
ABT 4Q21 Results by Business Segment [pre]
DewDiligence
01/26/22 12:18:35 PM
#739
ABT 2021 non-GAAP EPS=$5.21, above the prior guidance
DewDiligence
01/26/22 11:13:24 AM
#738
Good news is bad news.
wiwineguy
01/26/22 10:40:39 AM
#737
ABT announces line of consumer wearable biosensors—building on
DewDiligence
01/06/22 06:03:52 PM
#736
ABT hits all-time high on increased demand for
DewDiligence
12/27/21 05:58:31 PM
#735
ABT boosts dividend for 50th(!) consecutive year—new annualized
DewDiligence
12/10/21 05:57:22 PM
#734
ABT has essentially restored its 2021 non-GAAP EPS
DewDiligence
10/20/21 02:33:04 PM
#733
ABT 3Q21 CC transcript:
DewDiligence
10/20/21 02:19:22 PM
#732
ABT 3Q21 Results by Business Segment [pre]
DewDiligence
10/20/21 10:03:22 AM
#731
ABT 3Q21 results—2021_non-GAAP_EPS_guidance—>$5.00-5.10 (from $4.30-4.50):
DewDiligence
10/20/21 09:49:19 AM
#730
new 52 week high!
wiwineguy
09/02/21 06:50:23 PM
#729
ABT 2Q21 Results by Business Segment
[pre]
DewDiligence
07/22/21 09:26:57 AM
#728
ABT 2Q21 results—2021_non-GAAP-EPS_guidance_remains $4.30-4.50:
DewDiligence
07/22/21 09:21:23 AM
#727
good call wine guy!
wiwineguy
07/07/21 09:09:10 PM
#726
I'm back in down here
wiwineguy
06/13/21 02:42:57 PM
#725
A rare slip-up that doesn't mean much in
DewDiligence
06/01/21 03:16:48 PM
#724
Temporary fundamental negative. And ABT is going on
conix
06/01/21 03:07:26 PM
#723
ABT cuts_2021_non-GAAP_EPS_guidance_due to_slowdown_for_COVID_diagnostics:
DewDiligence
06/01/21 09:33:57 AM
#722
ABT 1Q21 CC transcript:
DewDiligence
04/20/21 04:53:03 PM
#721
ABT 1Q21 Results by Business Segment [pre]
DewDiligence
04/20/21 09:43:39 AM
#720
ABT _sold_$2.2B_of_COVID-19_diagnostics_in_1Q21 (down from $2.4B in 4Q20):
DewDiligence
04/20/21 09:20:39 AM
#719
$abt $120.75 ^ 0.97 (0.81%)
Taurus69
04/11/21 11:07:37 PM
#718
ABT’s BinaxNOW COVID-19_test_available_OTC—for_self_testing_w/o_prescription:
DewDiligence
04/01/21 09:43:00 AM
#717
ABT launches_4-in-1_test_for COVID/RSV/flu-A/flu-B:
DewDiligence
03/05/21 09:49:58 AM
#716
or $116...
wiwineguy
03/04/21 05:55:28 PM
#715
News today’s!
09yota
03/03/21 09:39:34 AM
#714
$abt $119.78 v -1.8 (-1.48%)
Taurus69
02/27/21 08:30:11 PM
#712
ABT dividend declared:
DewDiligence
02/19/21 02:02:49 PM
#711
back to $117
wiwineguy
02/18/21 10:13:37 AM
#710
nice run. But I feel pullback coming
wiwineguy
02/14/21 03:15:21 PM
#709
$abt $128.5 ^ 1.66 (1.31%)
Taurus69
02/12/21 07:06:06 PM
#708
Abbott earn a Zacks Rank #2 (Buy). The
wiwineguy
02/03/21 09:02:07 AM
#707
ABT Chart
conix
02/02/21 11:32:31 PM
#706
Wow, what a pop!
wiwineguy
01/28/21 10:38:02 AM
#705
ABT 4Q20 Results by Business Segment
[pre]
DewDiligence
01/27/21 09:17:26 AM
#704
ABT sold $2.4B of COVID-19 diagnostics during 4Q20!
DewDiligence
01/27/21 08:40:47 AM
#703
$abt $113.2 ^ 0.31 (0.27%)
Taurus69
01/21/21 11:26:31 PM
Post
Subject
Post New Msg
My Stocks (90)
Hide Intro
View Posters
ABT Poststream
Bans (0)
Hide Quote
Filter Disabled
Balance Available:
0
Get FREE PlusOneCoins!
© 2022 InvestorsHub.com, Inc.
Consent Preferences